AAI’s Moss Keynotes at GCR Live 2nd Pharmaceutical Conference

Diana Moss delivered keynote remarks at the Global Competition Review 2nd Pharmaceutical Conference in New York on February 27, 2020. The conference convened panels on drug pricing, merger activity, and litigation. Moss’s remarks highlighted the importance of vigorous antitrust enforcement in the sector, within the context of drug pricing and access as a broader public policy problem. She discussed other tools, including FDA regulation, patent reform, legislation, and the complementary roles they play with antitrust.